Eiki Ojima1, Yasuhiro Inoue, Chikao Miki, Masaki Mori, Masato Kusunoki. 1. Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, 514-8507, Japan.
Abstract
BACKGROUND: Our aim was to determine whether the expression levels of specific genes could predict clinical radiosensitivity in human colorectal cancer. METHODS: Radioresistant colorectal cancer cell lines were established by repeated X-ray exposure (total, 100 Gy), and the gene expressions of the parent and radioresistant cell lines were compared in a microarray analysis. To verify the microarray data, we carried out a reverse transcriptase-polymerase chain reaction analysis of identified genes in clinical samples from 30 irradiated rectal cancer patients. RESULTS: A comparison of the intensity data for the parent and three radioresistant cell lines revealed 17 upregulated and 142 downregulated genes in all radioresistant cell lines. Next, we focused on two upregulated genes, PTMA (prothymosin alpha) and EIF5a2 (eukaryotic translation initiation factor 5A), in the radioresistant cell lines. In clinical samples, the expression of PTMA was significantly higher in the minor effect group than in the major effect group (P = 0.004), but there were no significant differences in EIF5a2 expression between the two groups. CONCLUSIONS: We identified radiation-related genes in colorectal cancer and demonstrated that PTMA may play an important role in radiosensitivity. Our findings suggest that PTMA may be a novel marker for predicting the effectiveness of radiotherapy in clinical cases.
BACKGROUND: Our aim was to determine whether the expression levels of specific genes could predict clinical radiosensitivity in humancolorectal cancer. METHODS: Radioresistant colorectal cancer cell lines were established by repeated X-ray exposure (total, 100 Gy), and the gene expressions of the parent and radioresistant cell lines were compared in a microarray analysis. To verify the microarray data, we carried out a reverse transcriptase-polymerase chain reaction analysis of identified genes in clinical samples from 30 irradiated rectal cancerpatients. RESULTS: A comparison of the intensity data for the parent and three radioresistant cell lines revealed 17 upregulated and 142 downregulated genes in all radioresistant cell lines. Next, we focused on two upregulated genes, PTMA (prothymosin alpha) and EIF5a2 (eukaryotic translation initiation factor 5A), in the radioresistant cell lines. In clinical samples, the expression of PTMA was significantly higher in the minor effect group than in the major effect group (P = 0.004), but there were no significant differences in EIF5a2 expression between the two groups. CONCLUSIONS: We identified radiation-related genes in colorectal cancer and demonstrated that PTMA may play an important role in radiosensitivity. Our findings suggest that PTMA may be a novel marker for predicting the effectiveness of radiotherapy in clinical cases.
Authors: J E Staunton; D K Slonim; H A Coller; P Tamayo; M J Angelo; J Park; U Scherf; J K Lee; W O Reinhold; J N Weinstein; J P Mesirov; E S Lander; T R Golub Journal: Proc Natl Acad Sci U S A Date: 2001-09-11 Impact factor: 11.205
Authors: E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245
Authors: G Esposito; S Pucciarelli; R Alaggio; L Giacomelli; E Marchiori; G A Iaderosa; M L Friso; P Toppan; L Chieco-Bianchi; M Lise Journal: Ann Surg Oncol Date: 2001-05 Impact factor: 5.344
Authors: Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend Journal: Nature Date: 2002-01-31 Impact factor: 49.962
Authors: T R Hughes; M Mao; A R Jones; J Burchard; M J Marton; K W Shannon; S M Lefkowitz; M Ziman; J M Schelter; M R Meyer; S Kobayashi; C Davis; H Dai; Y D He; S B Stephaniants; G Cavet; W L Walker; A West; E Coffey; D D Shoemaker; R Stoughton; A P Blanchard; S H Friend; P S Linsley Journal: Nat Biotechnol Date: 2001-04 Impact factor: 54.908
Authors: Klaus Günther; Arno Dimmler; Franz Rödel; Udo Reulbach; Susanne Merkel; Birgit R Bittorf; Klaus E Matzel; Thomas Papadopoulos; Werner Hohenberger; Rolf Sauer; Claus Rödel Journal: J Surg Res Date: 2003-08 Impact factor: 2.192
Authors: O E Tsitsilonis; E Bekris; I F Voutsas; C N Baxevanis; C Markopoulos; S A Papadopoulou; K Kontzoglou; S Stoeva; J Gogas; W Voelter; M Papamichail Journal: Anticancer Res Date: 1998 May-Jun Impact factor: 2.480
Authors: Israel T Silva; Ricardo Z N Vêncio; Thiago Y K Oliveira; Greice A Molfetta; Wilson A Silva Journal: BMC Bioinformatics Date: 2010-03-30 Impact factor: 3.169
Authors: Pablo Palma; Carlos Cano; Raquel Conde-Muiño; Ana Comino; Pablo Bueno; J Antonio Ferrón; Marta Cuadros Journal: PLoS One Date: 2014-11-07 Impact factor: 3.240